Connect4strategies on Behalf of Orexo US, INC.
Orexo is a pharmaceutical manufacturer.
Based in MD
AI Overview
With $80K in lobbying spend across 8 quarterly filings, Connect4strategies on Behalf of Orexo US, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $80K |
| 2021 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Connect4strategies on Behalf of Orexo US, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
Drug shortage issues; issues related to medication assisted treatment
Drug shortage issues; issues related to medication assisted treatment
S. 3532, the Prescription Digital Therapeutics to Support Recovery Act
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.